Health questions and answers

CDC recommends three stringent options that combine chemical soaking with prolonged autoclaving for heat‑resistant instruments exposed to suspected CJD. Methods include immersing tools in 1N sodium hydroxide (NaOH) and autoclaving at 121°C for 30 minutes, or soaking in 1N NaOH or 20,000 ppm sodium hypochlorite for 1 hour followed by autoclaving at 121°C for 1 hour. A third option uses the same soak, then autoclaving for 1 hour at either 121°C (gravity) or 134°C (porous load), before routine cleaning/sterilization. CDC also notes that destroying heat‑resistant instruments is the safest approach when feasible and that all disposable items contacting potentially infected tissue should be incinerated.

CDC lists the brain, spinal cord, and eyes as high‑infectivity tissues for prions, which triggers stricter handling and decontamination measures for instruments contacting them. The guidance also distinguishes lower‑infectivity tissues—including cerebrospinal fluid, kidneys, liver, lungs, lymph nodes, spleen, and placenta—where prion levels are lower but still merit special surface and instrument precautions if exposure is suspected. CDC advises incinerating disposable items that contact potentially prion‑infected tissue and using defined chemical/autoclave protocols for reusable devices. This risk‑based tissue categorization helps perioperative teams decide when to quarantine, decontaminate, or discard instruments after procedures involving suspected CJD.

Beyond instrument reuse, documented iatrogenic CJD has occurred after cadaveric human growth hormone therapy, dura mater grafts, and corneal transplants. CDC notes that a small number of cases were historically linked to contaminated surgical or medical equipment but that such transmission has not been reported since 1976 following improved decontamination procedures. It also explains that people who received prion‑contaminated human growth hormone before 1978 may still develop iatrogenic CJD decades later, and that donor‑derived dura mater or corneal tissue can transmit disease if the donor had unrecognized CJD. These routes illustrate why tissue sourcing and device reprocessing standards became exceptionally strict.

Variant CJD differs from classic CJD by showing detectable prions in tonsils and other lymphoid tissues, whereas sporadic (classic) CJD does not. CDC’s scientific review highlights this pathologic difference along with vCJD’s younger median age at death and longer illness duration. The lymphoid distribution matters for infection control and surveillance because procedures involving tonsillar or other lymphoid tissues may pose different risks in suspected vCJD, influencing how specimens are handled and which tissues are prioritized for diagnostic testing or special precautions. This contrast underpins why guidance for tissue handling can diverge between vCJD and classic CJD contexts.

Yes—vCJD has been transmitted by blood transfusion, with three clinical cases and one asymptomatic infection reported in UK recipients of non‑leucodepleted red cell transfusions from donors later diagnosed with vCJD. UK authorities subsequently implemented public health precautions for patients who received UK‑sourced plasma products between 1980 and 2001 to minimize any onward transmission risk. Surveillance of individuals with potential exposure and risk‑reduction strategies around plasma products were strengthened in response. These findings informed broader blood‑safety policies, including donor deferral practices and heightened monitoring of recipients linked to at‑risk donors.

CDC recommends minimizing the number of central line hub accesses and blood draws, using bundled insertion and maintenance practices, considering alcohol-containing chlorhexidine for skin antisepsis when benefits outweigh risks, removing umbilical catheters and PICCs as soon as they are no longer needed, and implementing a dedicated catheter-care team. In units with ongoing CLABSIs, clinicians may also consider antimicrobial lock solutions as an adjunct to core strategies. These measures target risks introduced during hub manipulation and prolonged dwell time, and CDC frames several as conditional recommendations based on patient factors and local epidemiology.

Yes. CDC lists total parenteral nutrition as a common risk factor for invasive candidiasis, alongside central venous catheters, critical illness with prolonged ICU stay, and broad-spectrum antibiotics. The same page notes that preterm, very low birth weight infants are at higher risk, underscoring why careful line care and nutrition management matter in neonatal settings. CDC emphasizes prevention through hand hygiene, adherence to central line placement and maintenance recommendations, and antimicrobial stewardship, with neonatal candidiasis typically treated using amphotericin B deoxycholate or fluconazole based on clinical circumstances.

Hospitals prevent C. auris spread by using Contact Precautions (or Enhanced Barrier Precautions in nursing homes), rigorous hand hygiene, thorough daily and terminal environmental disinfection with EPA-registered products effective against C. auris (List P), and by cleaning and disinfecting shared equipment after each use. CDC also advises communicating a patient’s C. auris status during transfers and maintaining precautions for the entire inpatient stay because colonization can persist for many months. These steps are designed to interrupt transmission on high-touch surfaces and mobile equipment, which are frequent reservoirs during outbreaks.

A failure in the sterilization process at Meds IV, a Birmingham compounding pharmacy, appears to have contaminated total parenteral nutrition and caused Serratia marcescens bloodstream infections in 19 Alabama hospital patients, nine of whom died. Investigators found genetic matches of the bacteria on a water faucet, a container, and a mixing device used to prepare IV nutritional supplements at the pharmacy, and the outbreak was linked to TPN bags shipped to six hospitals in early 2011. The case highlighted the infection risks from contaminated compounded products entering intravenous lines.

Yes. CDC advises that when a NICU experiences ongoing CLABSIs despite core prevention strategies, clinicians may consider central line antimicrobial lock solutions as an adjunct. The guidance presents this as a conditional recommendation and emphasizes that locks supplement, not replace, standard insertion and maintenance bundles, minimizing hub access, and prompt removal of lines when not needed. The intent is to reduce intraluminal microbial burden in high-risk settings while broader bundle elements continue addressing manipulation risks and dwell-time–related infection drivers.

Chest CT is the key imaging test for a substernal goiter because it best defines size, retrosternal extent, relations to the trachea and vessels, and allows quantification of tracheal compression; MRI is an acceptable alternative when contrast is a concern. Ultrasound is useful for the cervical thyroid but cannot assess the intrathoracic portion due to bone and air limitations. Iodinated CT contrast may precipitate hyperthyroidism and also delays nuclear thyroid scans until iodine clears. StatPearls notes that CT can quantify airway narrowing and that marked tracheal compression (for example, a minimal tracheal diameter of 10 mm or less) helps guide the need for intervention.

Lung cancer and implanted medical devices are the most common current causes of superior vena cava syndrome. Cleveland Clinic explains that about seven in ten cases are malignant (most often lung cancer, but also lymphoma, breast cancer spread to mediastinal nodes, mesothelioma, or thymoma). Roughly three in ten are benign, now frequently related to intravascular devices; pacemakers, defibrillators, hemodialysis and central venous catheters can irritate the vein, trigger inflammation or scarring, and promote thrombosis. Other benign contributors include goiter, infections (such as tuberculosis or syphilis), noncancerous tumors, sarcoidosis, and post‑radiation scarring. This shift underscores how both oncology and device-related thrombosis drive modern SVCS patterns.

Clinicians commonly use the Adson maneuver and the Roos (elevated arm stress) test to screen for thoracic outlet syndrome (TOS). StatPearls describes Adson’s as extending and slightly abducting the shoulder, with neck extension and head rotation toward the examiner; diminution of the radial pulse suggests arterial compression. The Roos test abducts and externally rotates the shoulders with elbows at 90°, then repeatedly opens and closes the hands; reproduction of symptoms or fatigue supports TOS of any variant. Physical examination is the first diagnostic step; imaging such as chest or cervical spine X‑ray and, when appropriate, vascular studies can follow if bedside tests and history indicate TOS.

Surgery is recommended for symptomatic substernal goiter and for significant or fixed upper airway obstruction, with CT‑documented tracheal compression guiding urgency. StatPearls states that surgery is the treatment of choice when patients have compressive symptoms and that chest CT can quantify the degree of narrowing; a minimal tracheal diameter of 10 mm or less warrants intervention. Asymptomatic substernal goiters without marked compression may be observed with regular monitoring of symptoms, goiter size, tracheal diameter, and thyroid function, while avoiding excess iodine exposure that can trigger hyperthyroidism. This approach individualizes management around anatomy on imaging and the presence or absence of mechanical compromise.

A large or obstructively positioned goiter can narrow the airway or press on the voice box, leading to difficulty swallowing, exertional shortness of breath, cough, hoarseness, and snoring. Mayo Clinic notes that while many goiters are asymptomatic, those that obstruct the airway and larynx can cause these mechanical symptoms regardless of whether thyroid hormone levels are high, low, or normal. Management depends on cause, size, and symptom burden; small, nonobstructive goiters often need no treatment, but obstructive symptoms may prompt targeted therapy, including surgery when appropriate. Recognizing obstructive features helps distinguish cosmetic enlargement from clinically significant airway or laryngeal involvement.